Diseases, Conditions, Syndromes

US halts trials of plasma transfusions for COVID patients

US health experts said Tuesday they are halting clinical trials of convalescent blood plasma in patients with mild to moderate COVID symptoms after preliminary results showed no benefit from the treatment.

Gerontology & Geriatrics

Gut microbiome implicated in healthy aging and longevity

The gut microbiome is an integral component of the body, but its importance in the human aging process is unclear. ISB researchers and their collaborators have identified distinct signatures in the gut microbiome that are ...

Oncology & Cancer

Anti-cancer drug's mode of operation deciphered

Rituximab, an anti-cancer drug targeting the membrane protein CD20, was the first approved therapeutic antibody against B tumor cells. Immunologists at the University of Freiburg have now solved a mystery about how it works. ...

Diseases, Conditions, Syndromes

Research finds COVID plasma donation is fuelled by kindness

Researchers have given new insights into why people would choose to donate COVID-19 plasma after recovering from the virus, which will be used to support the recruitment of convalescent plasma donors to help treat current ...


New weapon for inflammation

Flinders University researchers have discovered a new anti-inflammatory role for well-known blood clot protein fibrinogen, which could support targeted new treatments for kidney, heart and other common diseases.

page 1 from 21